UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002930
Receipt number R000002882
Scientific Title pilot study of hepatic resection followed by intraarterial 5-fluorouracil/cisplatin combination therapy for advanced hepatocellular carcinoma with vascular invasion
Date of disclosure of the study information 2009/12/22
Last modified on 2013/07/18 20:20:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

pilot study of hepatic resection followed by intraarterial 5-fluorouracil/cisplatin combination therapy for advanced hepatocellular carcinoma with vascular invasion

Acronym

hepatic resection followed by low dose FP for HCC with vascular invasion

Scientific Title

pilot study of hepatic resection followed by intraarterial 5-fluorouracil/cisplatin combination therapy for advanced hepatocellular carcinoma with vascular invasion

Scientific Title:Acronym

hepatic resection followed by low dose FP for HCC with vascular invasion

Region

Japan


Condition

Condition

hepatocellular carcinoma with vascular invasion

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To elucidate the efficacy of hepatic resection followed by intraarterial 5-fluorouracil/cisplatin combination therapy for advanced hepatocellular carcinoma with vascular invasion

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

overall survival

Key secondary outcomes

1) time to progression
2) safety
3) response rate


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

1) hepatic resection
2) low dose FP
One course of chemotherapy represented 2 weeks. 5FU (300 mg/m2/24h) was administered using a mechanical infusion pump on days 1-5 of the first and second weeks. CDDP (6 mg/m2/0.5h) was administered using a mechanical infusion pump on days 1-5 of the first and second weeks. A 2- to 4-week rest period of no treatment was allowed after each treatment course. Treatment was repeatec unless HCC reveales progressive disease (acording to RECIST).

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Diagnosis of HCC was confirmed histopathologically or clinically.
2) no adaptation of liver transplantation and local abration.
3) with Vp3/4 or Vv2/3 or B3/4
4) without uncontrollable ascites
5) without hepatic coma
6) PS 0-1
7) chronic hepatitis or Child-Pugh A
8)
WBC > 3000/mm3
Plt > 80000/mm3
Hb > 10.0 g/dl
Total Bilirubin < 2.0 mg/dl
Albumin > 3 g/dl
Creatine < 1.2mg/dl
Prothromin time > 60 percentage

Key exclusion criteria

1) With other malignant disease.
2) A pregnant woman, or a woman suspected of pregnancy.
3) With severe infectious disease.
4) With history of severe allergy.
5) With severe renal function disease. 6) With severe allergy for 5FU or CDDP.
7) With severe bone marrow supression.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuaki Chayama

Organization

Hiroshima University

Division name

Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences

Zip code


Address

1-2-3 Kasumi, Minami-ku, Hiroshima

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Hiroshima University

Division name

Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Bio

Zip code


Address


TEL


Homepage URL


Email



Sponsor or person

Institute

Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical, Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical, Hiroshima University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 12 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2009 Year 09 Month 01 Day

Date of IRB


Anticipated trial start date

2009 Year 09 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 12 Month 22 Day

Last modified on

2013 Year 07 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002882


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name